Ziqi Ye Selected Research

Ziqi Ye Research Topics

Disease

11	Neoplasms (Cancer) 07/2022 - 01/2011
3	Breast Neoplasms (Breast Cancer) 09/2023 - 09/2019
3	Ulcerative Colitis 11/2022 - 05/2022
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2021 - 01/2011
2	Acute Kidney Injury (Acute Renal Failure) 04/2024 - 01/2024
2	Carcinogenesis 09/2023 - 08/2020
2	Cholangiocarcinoma 07/2023 - 01/2023
2	Weight Loss (Weight Reduction) 09/2022 - 05/2022
2	Adenocarcinoma of Lung 01/2021 - 01/2011
2	Pain (Aches) 01/2020 - 01/2020
2	Stomach Neoplasms (Stomach Cancer) 08/2019 - 01/2019
2	Fever (Fevers) 08/2019 - 01/2018
1	Colorectal Neoplasms (Colorectal Cancer) 01/2023
1	Chronic Obstructive Pulmonary Disease (COPD) 01/2023
1	Colitis 09/2022
1	Dysbiosis 09/2022
1	Microsatellite Instability 07/2022
1	Hemorrhage 09/2021
1	Peripheral Nervous System Diseases (PNS Diseases) 01/2021
1	Interstitial Lung Diseases (Interstitial Lung Disease) 10/2020
1	Liver Neoplasms (Liver Cancer) 08/2020
1	Postoperative Hemorrhage 05/2020
1	Nausea 05/2020
1	Neoplasm Metastasis (Metastasis) 01/2020
1	Arthritis (Polyarthritis) 01/2020
1	Critical Illness (Critically Ill) 01/2020
1	Low Back Pain (Lumbago) 01/2020
1	COVID-19 01/2020
1	Esophageal Squamous Cell Carcinoma 01/2020
1	Osteoarthritis 01/2020
1	Necrosis 08/2019
1	Thrombocytopenia (Thrombopenia) 01/2019
1	Leukopenia 01/2019
1	Multiple Myeloma 01/2019
1	Non-Muscle Invasive Bladder Neoplasms 01/2018
1	Cardiomegaly (Heart Hypertrophy) 09/2015

Drug/Important Bio-Agent (IBA)

4	Immune Checkpoint InhibitorsIBA 07/2023 - 01/2020
3	Biomarkers (Surrogate Marker)IBA 07/2022 - 01/2021
3	Proteins (Proteins, Gene)FDA Link 01/2020 - 09/2015
2	Polymyxin B (Aerosporin)FDA LinkGeneric 04/2024 - 01/2024
2	Colistin (Coly-Mycin)FDA Link 04/2024 - 01/2024
2	Liposomes (Liposome)IBA 09/2023 - 09/2019
2	RNA (Ribonucleic Acid)IBA 01/2023 - 08/2020
2	InflammasomesIBA 11/2022 - 09/2022
2	sanguinarineIBA 11/2022 - 09/2022
2	Sulfasalazine (Azulfidine)FDA LinkGeneric 09/2022 - 05/2022
2	Proteoglycans (Proteoglycan)IBA 04/2022 - 01/2020
1	Circular RNAIBA 09/2023
1	6-methyladenineIBA 01/2023
1	Therapeutic UsesIBA 09/2022
1	Caspase 1 (ICE Protease)IBA 09/2022
1	Dextrans (Dextran)FDA Link 05/2022
1	sodium sulfate (sodium bisulfate)FDA LinkGeneric 05/2022
1	OsteonectinIBA 04/2022
1	P-2 (P 2)IBA 04/2022
1	Tacrolimus (Prograf)FDA LinkGeneric 03/2022
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 03/2022
1	Sirolimus (Rapamycin)FDA Link 03/2022
1	Deubiquitinating EnzymesIBA 01/2022
1	sintilimabIBA 01/2022
1	Ubiquitin-Specific ProteasesIBA 01/2022
1	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 09/2021
1	Vitamin E FDA LinkGeneric 01/2021
1	Long Noncoding RNAIBA 01/2021
1	Paclitaxel (Taxol)FDA LinkGeneric 10/2020
1	Trastuzumab (Herceptin)FDA Link 10/2020
1	Alpha-Ketoglutarate-Dependent Dioxygenase FTOIBA 08/2020
1	N-methyladenosineIBA 08/2020
1	Prostaglandins AIBA 01/2020
1	Fentanyl (Sublimaze)FDA LinkGeneric 01/2020
1	AntibodiesIBA 01/2020
1	Ritonavir (Norvir)FDA Link 01/2020
1	Matrix Metalloproteinase 9 (Gelatinase B)IBA 01/2020
1	Nerve Growth Factor (NGF)IBA 01/2020
1	CateninsIBA 01/2020
1	umifenovirIBA 01/2020
1	Lopinavir FDA Link 01/2020
1	NucleolinIBA 09/2019
1	ChemokinesIBA 08/2019
1	SubtilisinIBA 08/2019
1	UbiquitinIBA 08/2019
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 08/2019
1	Myelin Basic ProteinIBA 08/2019
1	Proprotein Convertases (Pro-Opiomelanocortin Converting Enzyme)IBA 08/2019
1	Interleukin-6 (Interleukin 6)IBA 08/2019
1	Notch ReceptorsIBA 08/2019
1	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 08/2019
1	Cell Surface ReceptorsIBA 08/2019
1	Bortezomib (Velcade)FDA Link 01/2019
1	Capecitabine (Xeloda)FDA Link 01/2019
1	Gemcitabine FDA Link 01/2018
1	endonuclease GIBA 09/2015
1	Phenylephrine (Neo-Synephrine)FDA LinkGeneric 09/2015

Therapy/Procedure

11	Therapeutics 04/2024 - 01/2018
2	Radiotherapy 01/2021 - 01/2020
2	Drug Therapy (Chemotherapy) 01/2021 - 01/2020
2	Length of Stay 05/2020 - 01/2020
1	Kidney Transplantation 03/2022
1	Catheters 05/2020
1	Transdermal Patch 01/2020